Aberrant down-regulation of the ERK pathway can be associated with some neurodegenerative or autoimmune disorders, while its abnormal upregulation is associated with human cancers, rasopathies, and Erdheim-Chester disease66–69. This evidence concerns the gene MAPK1 and cancer.